1. Orlistat-induced oxalate nephropathy: an under-recognised cause of chronic kidney disease.
- Author
-
Solomon LR, Nixon AC, Ogden L, and Nair B
- Subjects
- Aged, Anti-Obesity Agents administration & dosage, Calcium Oxalate urine, Female, Humans, Hyperoxaluria diagnostic imaging, Kidney Tubular Necrosis, Acute diagnostic imaging, Kidney Tubular Necrosis, Acute pathology, Lactones administration & dosage, Male, Microscopy, Obesity drug therapy, Orlistat, Anti-Obesity Agents adverse effects, Hyperoxaluria chemically induced, Kidney Tubular Necrosis, Acute chemically induced, Lactones adverse effects, Renal Insufficiency, Chronic chemically induced
- Abstract
Two patients developed kidney failure due to oxalate deposition in the kidney while taking orlistat. Cessation of orlistat was followed by partial recovery of kidney function. The mechanism by which orlistat causes hyperoxaluria and the management of orlistat-induced oxalate nephropathy is reviewed. We suggest that all patients taking orlistat are at risk of this condition, which may develop insidiously and is easily overlooked. Monitoring of kidney function of patients taking orlistat is warranted., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)
- Published
- 2017
- Full Text
- View/download PDF